nf 279 has been researched along with adenosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anyanwu, AC; Burant, CF; Goonewardena, SN; Hyman, MC; Kanthi, Y; Petrovic-Djergovic, D; Pinsky, DJ; Rattan, R; Robichaud, P; Visovatti, SH; Wang, J | 1 |
1 other study(ies) available for nf 279 and adenosine
Article | Year |
---|---|
Purinergic dysregulation in pulmonary hypertension.
Topics: Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Antihypertensive Agents; Apyrase; Arterial Pressure; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Hydrolysis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Pulmonary Artery; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X1; Severity of Illness Index; Signal Transduction; Suramin; Vascular Remodeling; Ventricular Remodeling | 2016 |